Millions of children in Pakistan to be protected against pneumococcal disease with GSKÂ’s Synflorix

Millions of children in Pakistan to be protected against pneumococcal disease with GSKÂ’s Synflorix

By: 1888PressRelease - Full Feed

Posted on October 09, 2012 at 08:27 AM EDT

WorldÂ’s largest pneumococcal mass vaccination programme is expected to protect up to 4.8 million children in Pakistan from pneumococcal disease. Pakistan is the first GAVI eligible country in south Asia to introduce pneumococcal vaccines

Related Stocks:

GlaxoSmithKline PLC ADS

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates